368 related articles for article (PubMed ID: 12434417)
1. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
van Houten VM; Tabor MP; van den Brekel MW; Kummer JA; Denkers F; Dijkstra J; Leemans R; van der Waal I; Snow GB; Brakenhoff RH
J Pathol; 2002 Dec; 198(4):476-86. PubMed ID: 12434417
[TBL] [Abstract][Full Text] [Related]
2. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study.
van Houten VM; Leemans CR; Kummer JA; Dijkstra J; Kuik DJ; van den Brekel MW; Snow GB; Brakenhoff RH
Clin Cancer Res; 2004 Jun; 10(11):3614-20. PubMed ID: 15173067
[TBL] [Abstract][Full Text] [Related]
3. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck.
Brennan JA; Mao L; Hruban RH; Boyle JO; Eby YJ; Koch WM; Goodman SN; Sidransky D
N Engl J Med; 1995 Feb; 332(7):429-35. PubMed ID: 7619114
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ
Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
[TBL] [Abstract][Full Text] [Related]
5. Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study.
Tabor MP; Brakenhoff RH; Ruijter-Schippers HJ; Kummer JA; Leemans CR; Braakhuis BJ
Clin Cancer Res; 2004 Jun; 10(11):3607-13. PubMed ID: 15173066
[TBL] [Abstract][Full Text] [Related]
6. Status of primary tumour surgical margins in squamous head and neck cancer: prognostic implications.
Bradley PJ; MacLennan K; Brakenhoff RH; Leemans CR
Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):74-81. PubMed ID: 17413406
[TBL] [Abstract][Full Text] [Related]
7. Mapping of resection margins of oral cancer for p53 overexpression and chromosome instability to detect residual (pre)malignant cells.
van der Toorn PP; Veltman JA; Bot FJ; de Jong JM; Manni JJ; Ramaekers FC; Hopman AH
J Pathol; 2001 Jan; 193(1):66-72. PubMed ID: 11169517
[TBL] [Abstract][Full Text] [Related]
8. Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers.
Kropveld A; Rozemuller EH; Leppers FG; Scheidel KC; de Weger RA; Koole R; Hordijk GJ; Slootweg PJ; Tilanus MG
Lab Invest; 1999 Mar; 79(3):347-53. PubMed ID: 10092071
[TBL] [Abstract][Full Text] [Related]
9. Clinical applications of the diagnosis of p53 alterations in squamous cell carcinoma of the head and neck.
Lopez-Martinez M; Anzola M; Cuevas N; Aguirre JM; De-Pancorbo M
Med Oral; 2002; 7(2):108-20. PubMed ID: 11887018
[TBL] [Abstract][Full Text] [Related]
10. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications.
Tabor MP; Brakenhoff RH; van Houten VM; Kummer JA; Snel MH; Snijders PJ; Snow GB; Leemans CR; Braakhuis BJ
Clin Cancer Res; 2001 Jun; 7(6):1523-32. PubMed ID: 11410486
[TBL] [Abstract][Full Text] [Related]
11. Molecular assays for the diagnosis of minimal residual head-and-neck cancer: methods, reliability, pitfalls, and solutions.
van Houten VM; Tabor MP; van den Brekel MW; Denkers F; Wishaupt RG; Kummer JA; Snow GB; Brakenhoff RH
Clin Cancer Res; 2000 Oct; 6(10):3803-16. PubMed ID: 11051222
[TBL] [Abstract][Full Text] [Related]
12. Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck.
Fouret P; Temam S; Charlotte F; Lacau-St-Guily J
Br J Cancer; 2002 Dec; 87(12):1390-5. PubMed ID: 12454767
[TBL] [Abstract][Full Text] [Related]
13. Analysis of tumor suppressor p53 status in head and neck squamous cell carcinoma.
Smardova J; Ksicova K; Binkova H; Krpensky A; Pavlova S; Rottenberg J; Koukalova H
Oncol Rep; 2004 Apr; 11(4):923-9. PubMed ID: 15010896
[TBL] [Abstract][Full Text] [Related]
14. p53 mutations in deep tissues are more strongly associated with recurrence than mutation-positive mucosal margins.
Huang X; Pateromichelakis S; Hills A; Sherriff M; Lyons A; Langdon J; Odell E; Morgan P; Harrison J; Partridge M
Clin Cancer Res; 2007 Oct; 13(20):6099-106. PubMed ID: 17947474
[TBL] [Abstract][Full Text] [Related]
15. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
Kawasaki H; Ogura T; Yokose T; Nagai K; Nishiwaki Y; Esumi H
Hum Pathol; 2001 Oct; 32(10):1043-9. PubMed ID: 11679937
[TBL] [Abstract][Full Text] [Related]
16. p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy.
Ganly I; Soutar DS; Brown R; Kaye SB
Br J Cancer; 2000 Jan; 82(2):392-8. PubMed ID: 10646894
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal study of TP53 mutations in eight patients with potentially malignant oral mucosal disorders.
Ogmundsdóttir HM; Hilmarsdóttir H; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Oct; 38(9):716-21. PubMed ID: 19473449
[TBL] [Abstract][Full Text] [Related]
18. Molecular diagnosis of head and neck cancer.
van Houten VM; van den Brekel MW; Denkers F; Colnot DR; Westerga J; van Diest PJ; Snow GB; Brakenhoff RH
Recent Results Cancer Res; 2000; 157():90-106. PubMed ID: 10857164
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of surgical margins in head and neck cancer: more than a marginal issue.
Braakhuis BJ; Bloemena E; Leemans CR; Brakenhoff RH
Oral Oncol; 2010 Jul; 46(7):485-91. PubMed ID: 20189442
[TBL] [Abstract][Full Text] [Related]
20. Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis.
Coulet F; Blons H; Cabelguenne A; Lecomte T; Lacourreye O; Brasnu D; Beaune P; Zucman J; Laurent-Puig P
Cancer Res; 2000 Feb; 60(3):707-11. PubMed ID: 10676657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
